Economic Analysis of the Tailored Activity Program: A Nonpharmacological Approach to Improve Quality of Life in People Living With Dementia and their Caregivers

Abstract

We investigated costs of delivering the Tailored Activity Program (TAP) and cost savings from two perspectives (health sector and societal) for people living with dementia (PLWD) and their caregivers (dyads) compared to attention control (AC) using data from a randomized controlled trial. The evaluation assessed intervention delivery costs and caregiver reported health care utilization. The total intervention cost of TAP was $1707/dyad versus $864/dyad for AC, and total costs over 6 months for TAP dyads as compared to AC were $1299 (CI: -$10,496, $7898) less from the healthcare perspective, and $761 (CI: -$10,133, $8611) less from the societal perspective. TAP cost savings are driven by lower use of healthcare services among participating dyads, but further analyses with larger samples is warranted to confirm its financial impact.

Keywords

dementia costs caregivers healthcare utilization economic evaluation

Get full access to this article

View all access options for this article.

References

Acumen . (2018). Skilled nursing facilities patient-driven payment model technical report, April 2018. http://www.cms.gov/Medicare/Medicare-Fee-for-Service-Payment/SNFPPS/Downloads/PDPM_Technical_Report_508.pdf

American Medical Association . (2017). National fee analyzer: Charge data for evaluating fees nationally 2017. Ingenix.

Boustani

Alder

C. A.

Solid

C. A.

Reuben

(2019, Jan). An alternative payment model to support widespread use of collaborative dementia care models. Health Affairs (Project Hope), 38(1), 54–59. https://doi.org/10.1377/hlthaff.2018.05154

Buck

C. J.

(2017). 2017 HCPCS level II professional edition-e-book. Elsevier Health Sciences.

Bureau of Labor Statistics . (2017). Overview of BLS wage data by area and occupation. https://www.bls.gov/bls/blswage.htm

CHRONIC Care Act of 2017 . (2017). Creating high-quality results and outcomes necessary to improve chronic (CHRONIC) care act of 2017. S. 870, 115th Cong. https://www.congress.gov/bill/115th-congress/senate-bill/870/text

Cohen-Mansfield

Marx

M. S.

Dakheel-Ali

Regier

N. G.

Thein

Freedman

(2010, Aug). Can agitated behavior of nursing home residents with dementia be prevented with the use of standardized stimuli? Journal of the American Geriatrics Society, 58(8), 1459–1464. https://doi.org/10.1111/j.1532-5415.2010.02951.x

Dimick

J. B.

Ryan

A. M.

(2014). Methods for evaluating changes in health care policy: The difference-in-differences approach. JAMA, 312(22), 2401–2402. https://doi.org/10.1001/jama.2014.16153

Folstein

M. F.

Folstein

S. E.

McHugh

P. R.

(1975, Nov). “Mini-mental state”. A practical method for grading the cognitive state of patients for the clinician. Journal of Psychiatric Research, 12(3), 189–198. https://doi.org/10.1016/0022-3956(75)90026-6

10.

Fortinsky

R. H.

Gitlin

L. N.

Pizzi

L. T.

Piersol

C. V.

Grady

Robison

J. T.

Molony

(2016). Translation of the Care of Persons with Dementia in their Environments (COPE) intervention in a publicly-funded home care context: Rationale and research design. Contemporary Clinical Trials, 49, 155–165. https://doi.org/10.1016/j.cct.2016.07.006

11.

Gertler

P. J.

Martinez

Premand

Rawlings

L. B.

Vermeersch

C. M.

(2016). Impact evaluation in practice (pp. 129–142). The World Bank.

12.

Gitlin

L. N.

Arthur

Piersol

Hessels

S. S.

Dai

Mann

W. C.

(2018, Feb). Targeting behavioral symptoms and functional decline in dementia: A randomized clinical trial. Journal of the American Geriatrics Society, 66(2), 339–345. https://doi.org/10.1111/jgs.15194

13.

Gitlin

L. N.

Hodgson

Jutkowitz

Pizzi

(2010). The cost-effectiveness of a nonpharmacologic intervention for individuals with dementia and family caregivers: The tailored activity program. The American Journal of Geriatric Psychiatry: official Journal of the American Association for Geriatric Psychiatry, 18(6), 510–519. https://doi.org/10.1097/JGP.0b013e3181c37d13

14.

Gitlin

L. N.

Winter

Burke

Chernett

Dennis

M. P.

Hauck

W. W.

(2008). Tailored activities to manage neuropsychiatric behaviors in persons with dementia and reduce caregiver burden: A randomized pilot study. The American Journal of Geriatric Psychiatry: official Journal of the American Association for Geriatric Psychiatry, 16(3), 229–239. https://doi.org/10.1097/JGP.0b013e318160da72

15.

Jutkowitz

Kane

R. L.

Gaugler

J. E.

MacLehose

R. F.

Dowd

Kuntz

K. M.

(2017, Oct). Societal and family lifetime cost of dementia: Implications for policy. Journal of the American Geriatrics Society, 65(10), 2169–2175. https://doi.org/10.1111/jgs.15043

16.

Jutkowitz

Scerpella

Pizzi

L. T.

Marx

Samus

Piersol

C. V.

Gitlin

L. N.

(2019). Dementia family caregivers’ willingness to pay for an in-home program to reduce behavioral symptoms and caregiver stress. Pharmacoeconomics, 37(4), 563–572. https://doi.org/10.1007/s40273-019-00785-6

17.

Kaplan

R. S.

Anderson

S. R.

(2003). Time-driven activity-based costing. Available at SSRN 485443.

18.

Kelley

A. S.

McGarry

Bollens-Lund

Rahman

O. K.

Husain

Ferreira

K. B.

Skinner

J. S.

(2020). Residential setting and the cumulative financial burden of dementia in the 7 Years before death. Journal of the American Geriatrics Society, 68(6), 1319–1324. https://doi.org/10.1111/jgs.16414

19.

Kolanowski

Buettner

(2008). Prescribing activities that engage passive residents. An innovative method. Journal of Gerontological Nursing, 34(1), 13–18. https://doi.org/10.3928/00989134-20080101-08

20.

Kolanowski

A. M.

Litaker

Buettner

(2005). Efficacy of theory-based activities for behavioral symptoms of dementia. Nursing Research, 54(4), 219–228, https://doi.org/10.1097/00006199-200507000-00003

21.

Long

K. H.

Moriarty

J. P.

Mittelman

M. S.

Foldes

S. S.

(2014). Estimating the potential cost savings from the New York university caregiver intervention in Minnesota. Health Affairs (Project Hope), 33(4), 596–604. https://doi.org/10.1377/hlthaff.2013.1257

22.

Morris

J. C.

(1993). The clinical dementia rating (CDR): Current version and scoring rules. Neurology, 43(11), 2412–2414. https://doi.org/10.1212/wnl.43.11.2412-a

23.

Murman

D. L.

Chen

Powell

M. C.

Kuo

S. B.

Bradley

C. J.

Colenda

C. C.

(2002). The incremental direct costs associated with behavioral symptoms in AD. Neurology, 59(11), 1721–1729. https://doi.org/10.1212/01.wnl.0000036904.73393.e4

24.

Nichols

L. O.

Martindale-Adams

Zhu

C. W.

Kaplan

E. K.

Zuber

J. K.

Waters

T. M.

(2017). Impact of the REACH II and REACH VA dementia caregiver interventions on healthcare costs. Journal of the American Geriatrics Society, 65(5), 931–936. https://doi.org/10.1111/jgs.14716

25.

Penrod

J. D.

Kane

R. L.

Finch

M. D.

Kane

R. A.

(1998). Effects of post-hospital Medicare home health and informal care on patient functional status. Health Services Research, 33(3 Pt 1), 513–529.

26.

Pizzi

L. T.

Jutkowitz

Frick

K. D.

Suh

D. C.

Prioli

K. M.

Gitlin

L. N.

(2014). Cost-effectiveness of a community-integrated home-based depression intervention in older African Americans. Journal of the American Geriatrics Society, 62(12), 2288–2295. https://doi.org/10.1111/jgs.13146

27.

Pizzi

L. T.

Jutkowitz

Nyman

(2016). Economic evaluations of behavioral interventions. In Gitlin

Czaja

(Eds.), Behavioral intervention research: Designing, evaluating, and implementing (pp. 333–357). springer publishing company.

28.

Pizzi

L. T.

Jutkowitz

Prioli

K. M.

E. Y.

Babcock

McAbee-Sevick

Wakefield

D. B.

Robison

Molony

Piersol

C. V.

Gitlin

L. N.

Fortinsky

R. H.

(2022). Cost-benefit analysis of the COPE program for persons living with dementia: Toward a payment model. Innovation in Aging, 6(1), igab042, igab042. https://doi.org/10.1093/geroni/igab042

29.

Rahja

Nguyen

K. H.

Laver

Clemson

Crotty

Comans

(2020, May 19). Implementing an evidence-based dementia care program in the Australian health context: A cost-benefit analysis. Health Soc Care Community. https://doi.org/10.1111/hsc.13013

30.

Rattinger

G. B.

Schwartz

Mullins

C. D.

Corcoran

Zuckerman

I. H.

Sanders

Norton

M. C.

Fauth

E. B.

Leoutsakos

J.-M. S.

Lyketsos

C. G.

Tschanz

J. T.

(2015). Dementia severity and the longitudinal costs of informal care in the Cache County population. Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 11(8), 946–954. https://doi.org/10.1016/j.jalz.2014.11.004

31.

Ray

Prioli

Jutkowitz

Gitlin

Rovner

Casten

Pizzi

(2019). PMU105 impact of behavioral interventions for chronic diseases on health utility: Assessment of three trials of older adults. Value in Health, 22, S268. https://doi.org/10.1016/j.jval.2019.04.1266

32.

Reuben

Possin

K. L.

Epstein-Ludlow

Borson

S. T.

Angalos

E. G.

Lamba

(2020). Dementia care management: A proposed framework for an alternative payment model alzheimer’s association https://alzimpact.org/media/serve/id/5f1b511b98110

33.

Sanders

G. D.

Neumann

P. J.

Basu

Brock

D. W.

Feeny

Krahn

Kuntz

K. M.

Meltzer

D. O.

Owens

D. K.

Prosser

L. A.

Salomon

J. A.

Sculpher

M. J.

Trikalinos

T. A.

Russell

L. B.

Siegel

J. E.

Ganiats

T. G.

(2016). Recommendations for conduct, methodological practices, and reporting of cost-effectiveness analyses: Second panel on cost-effectiveness in health and medicine. JAMA, 316(10), 1093–1103. https://doi.org/10.1001/jama.2016.12195

34.

Twisk

Bosman

Hoekstra

Rinjhart

Welte

Heymans

(2018). Different ways to estimate treatment effects in randomised controlled trials. . Contemporary Clinical Trials Communications, 10, 80–85. https://doi.org/10.1016/j.conctc.2018.03.008

35.

U.S. Department of Health & Human Services . Healthcare cost and utilization Project. Agency for Healthcare Research and Quality. http://www.ahrq.gov

36.

Wimo

Jonsson

Zbrozek

(2010). The Resource Utilization in Dementia (RUD) instrument is valid for assessing informal care time in community-living patients with dementia. The Journal of Nutrition, Health & Aging, 14(8), 685–690. https://doi.org/10.1007/s12603-010-0316-2

37.

Wing

Simon

Bello-Gomez

R. A.

(2018). Designing difference in difference studies: Best practices for public health policy research. Annual Review of Public Health, 39, 453–469. https://doi.org/10.1146/annurev-publhealth-040617-013507

38.

Yang

Lin

P. J.

Levey

(2013). Monetary costs of dementia in the United States. The New England Journal of Medicine, 369(5), 489–490. https://doi.org/10.1056/NEJMc1305541

39.

Zhou

Taber

Arcona

(2016). Difference-in-differences method in comparative effectiveness research: Utility with unbalanced groups. Applied Health Economics and Health Policy, 14(4), 419–429. https://doi.org/10.1007/s40258-016-0249-y

40.

Zhu

C. W.

Scarmeas

Torgan

Albert

Brandt

Blacker

Sano

Stern

(2006). Longitudinal study of effects of patient characteristics on direct costs in Alzheimer disease. Neurology, 67(6), 998–1005. https://doi.org/10.1212/01.wnl.0000230160.13272.1b

Supplementary Material

Please find the following supplemental material available below.

For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.

For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.

0.00 MB

0.49 MB